Literature DB >> 2184712

Hypercholesterolemia in elderly persons: resolving the treatment dilemma.

M A Denke1, S M Grundy.   

Abstract

Of all age groups, men and women over 60 years of age have the highest prevalence of elevated serum cholesterol levels. Now that detection and treatment of high serum cholesterol levels are increasing, we need a rational approach to managing elevated cholesterol levels in elderly patients. Recent data indicate that high total cholesterol and low-density lipoprotein levels predict risk for coronary heart disease in patients over 60 years of age. However, selecting appropriate candidates for cholesterol-lowering therapy requires clinical judgment of the relative risks and benefits of each therapy and consideration of each patient's overall health status as well as of competing risks. Active medical management of high cholesterol levels, therefore, should be restricted to a limited fraction of elderly patients who are most likely to benefit from long-term therapy. The first line of treatment is diet modification; however, drug therapy for appropriate patients is not contraindicated because of age alone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184712     DOI: 10.7326/0003-4819-112-10-780

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

Review 1.  HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.

Authors:  C J Lintott; R S Scott
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

Review 2.  Management strategies of dyslipidemia in the elderly: 2005.

Authors:  Tarek Helmy; Amar D Patel; Fadi Alameddine; Nanette K Wenger
Journal:  MedGenMed       Date:  2005-10-10

Review 3.  The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

Review 4.  Hypercholesterolaemia in aged patients. To treat or not to treat?

Authors:  M J Tikkanen; R S Tilvis
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

Review 5.  Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: opportunities and challenges.

Authors:  Jennifer G Robinson
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 6.  Management of lipids in the elderly.

Authors:  A Winder
Journal:  J R Soc Med       Date:  1998-04       Impact factor: 5.344

7.  Comprehensive Geriatric Assessment in the Office: Uncovering all the problems of geriatric patients.

Authors:  L R Pereles; N G Boyle
Journal:  Can Fam Physician       Date:  1991-10       Impact factor: 3.275

8.  Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men.

Authors:  Jennifer G Robinson; Catherine Rahilly-Tierney; Elizabeth Lawler; J Michael Gaziano
Journal:  J Clin Lipidol       Date:  2011-11-07       Impact factor: 4.766

Review 9.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 10.  Epidemiological considerations in the prevention of coronary heart disease among the elderly.

Authors:  A Nissinen; O Siitonen
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.